Veterinary Medicines

Noroclav 250 mg Tablets for dogs

Authorised
  • Potassium clavulanate
  • Amoxicillin trihydrate
Download as PDF

Product identification

Medicine name:
Noroclav 250 mg Tablets for dogs
Noroclav Vet. 200+50 mg tabletter
Active substance:
  • Potassium clavulanate
  • Amoxicillin trihydrate
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Potassium clavulanate
    59.56
    milligram(s)
    /
    1.00
    Tablet
  • Amoxicillin trihydrate
    229.61
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01CR02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Denmark
Available in:
  • Denmark
Package description:
  • The product is supplied in high-density polyethylene tubs with a polyethylene screw cap lid containing 100 tablets.
  • The product is supplied in high-density polyethylene tubs with a polyethylene screw cap lid containing 250 tablets.
  • The product is presented in packs of 2 blister strips (aluminium-aluminium) each containing 5 tablets per strip.
  • The product is presented in packs of 4 blister strips (aluminium-aluminium) each containing 5 tablets per strip.
  • The product is presented in packs of 10 blister strips (aluminium-aluminium) each containing 5 tablets per strip.
  • The product is presented in packs of 20 strips (aluminium-aluminium) each containing 5 tablets per strip.
  • The product is also presented in packs of 50 blister strips (aluminium-aluminium) each containing 5 tablets per strip.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Norbrook Laboratories (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Norbrook Laboratories Limited
  • Norbrook Manufacturing Limited
Responsible authority:
  • Danish Medicines Agency
Authorisation number:
  • 35925
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0546/002
Concerned member states:
  • Austria
  • Belgium
  • Denmark
  • France
  • Luxembourg
  • Netherlands
  • Norway
  • Portugal
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 13/04/2025
Download
Danish (, TABLETTER 200 MG + 50 MG)
Published on: 5/05/2025
Download

Combined File of all Documents

English (PDF)
Published on: 13/04/2025
Download